These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Disturbed nitric oxide/endothelin-1 equilibrium in cultured human placental endotheliocytes in preeclampsia. Leszczyńska-Gorzelak B; Oleszczuk J; Kamiński K; Szymula D; Gorzelak M; Oleszczuk JJ Gynecol Obstet Invest; 1998; 46(3):145-9. PubMed ID: 9736792 [TBL] [Abstract][Full Text] [Related]
27. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Shah DA; Khalil RA Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268 [TBL] [Abstract][Full Text] [Related]
28. Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Powers RW; Roberts JM; Plymire DA; Pucci D; Datwyler SA; Laird DM; Sogin DC; Jeyabalan A; Hubel CA; Gandley RE Hypertension; 2012 Jul; 60(1):239-46. PubMed ID: 22647886 [TBL] [Abstract][Full Text] [Related]
29. Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production. Palmer KR; Tong S; Tuohey L; Cannon P; Ye L; Hannan NJ; Brownfoot FC; Illanes SE; Kaitu'u-Lino TJ Biol Reprod; 2016 Mar; 94(3):59. PubMed ID: 26819475 [TBL] [Abstract][Full Text] [Related]
31. Fractional excretion of angiogenic factors in women with severe preeclampsia. Buhimschi CS; Magloire L; Funai E; Norwitz ER; Kuczynski E; Martin R; Richman S; Guller S; Lockwood CJ; Buhimschi IA Obstet Gynecol; 2006 May; 107(5):1103-13. PubMed ID: 16648417 [TBL] [Abstract][Full Text] [Related]
32. Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction. Wang CN; Chang SD; Peng HH; Lee YS; Chang YL; Cheng PJ; Chao AS; Wang TH; Wang HS J Clin Endocrinol Metab; 2010 Mar; 95(3):1431-41. PubMed ID: 20080845 [TBL] [Abstract][Full Text] [Related]
33. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy. Ren Z; Cui N; Zhu M; Khalil RA Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955 [TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanisms of Preeclampsia. Hod T; Cerdeira AS; Karumanchi SA Cold Spring Harb Perspect Med; 2015 Aug; 5(10):. PubMed ID: 26292986 [TBL] [Abstract][Full Text] [Related]
35. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Spradley FT; Palei AC; Granger JP Am J Physiol Regul Integr Comp Physiol; 2015 Dec; 309(11):R1326-43. PubMed ID: 26447211 [TBL] [Abstract][Full Text] [Related]
36. Angiogenic factors and preeclampsia. Tjoa ML; Levine RJ; Karumanchi SA Front Biosci; 2007 Jan; 12():2395-402. PubMed ID: 17127249 [TBL] [Abstract][Full Text] [Related]
37. Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment. Saleh L; Danser JA; van den Meiracker AH Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):94-9. PubMed ID: 26717314 [TBL] [Abstract][Full Text] [Related]